BANK VONTOBEL/CALL/CVS HEALTH/60/0.1/20.09.24 Stock

Warrant

DE000VD5J4H7

Market Closed - Boerse Frankfurt Warrants 13:52:33 2024-06-26 EDT
0.35 EUR -5.41% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/60/0.1/20.09.24
Current month+20.69%
1 month+90.22%
Date Price Change
24-06-26 0.35 -5.41%
24-06-25 0.37 -9.76%
24-06-24 0.41 +7.89%
24-06-21 0.38 -5.00%
24-06-20 0.4 0.00%

Real-time Boerse Frankfurt Warrants

Last update June 26, 2024 at 01:52 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD5J4H
ISINDE000VD5J4H7
Date issued 2024-05-03
Strike 60 $
Maturity 2024-09-20 (86 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.45
Lowest since issue 0.114
Spread 0.01
Spread %2.78%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
60.63 USD
Average target price
69.1 USD
Spread / Average Target
+13.96%
Consensus